Dec. 20, 2024
by Thomas Fessard
Biopharma insight
Sponsored by SpiroChem
As we approach 2025, the role of chemistry Contract Research Organizations (CROs) is undergoing profound transformation. Chemistry is no longer …
Nov. 5, 2024
by Andrey Doronichev
Biopharma insight
Sponsored by OPTIC
The global drug development landscape is bustling, with over 20,000 biotechs competing for investor attention. Now more than ever, having …
Oct. 22, 2024
by Andrii Buvailo, PhD
Interview
Sponsored by MEDSIR
MEDSIR (Medica Scientia Innovation Research) is an international company, based in Barcelona and New Jersey, specializing in the design and …
April 18, 2024
by Andrii Buvailo, PhD
Interview
Sponsored by Trialize
In an industry as critical as clinical trials, where efficient data management and swift processes are paramount, outdated tech methods …
April 8, 2024
by Andrii Buvailo
Biopharma insight
Sponsored by Lantern Pharma
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
April 8, 2024
by Dimitrios Skaltsas, Bara Badwan, Panos Karelis
Sponsored by Intelligencia AI
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often …
April 1, 2024
Case study
Sponsored by Trialize
In the realm of clinical trials, efficient data management and monitoring are crucial yet often hampered by outdated and time-consuming …
The field of AI ligand pose prediction in the protein binding pockets (aka “AI docking”) witnessed unprecedented development in the …
Feb. 19, 2024
by Andrii Buvailo, PhD
Biopharma insight
Sponsored by RECEPTOR.AI
Receptor.AI, a London-based drug discovery company and NVIDIA Inception member, has successfully integrated NVIDIA BioNeMo cloud APIs with their end-to-end …
The development of oncology drugs faces significant challenges, including a high failure rate (97%) in clinical trials, due to complex …
We at Receptor.AI are excited to present the next important milestone in the development of our next-generation AI docking model, …
Dec. 28, 2023
by Andrii Buvailo
Biopharma insight
Sponsored by Lantern Pharma
The sphere of oncology continues to grapple with the complex nature of brain and central nervous system (CNS) tumors. Data …